CAS: 1346528-06-0

ML241 is a small molecule inhibitor, which is derived from a chemical synthesis process aimed at developing compounds for targeted cancer therapies. With a specific mode of action as a selective antagonist, ML241 inhibits cancer cell growth by targeting a specific signaling pathway or protein involved in cell proliferation. This targeted inhibition allows scientists to explore the molecular mechanisms within tumor environments and investigate potential therapeutic strategies that could be extended to clinical applications. ML241 is utilized primarily in preclinical studies, serving as a crucial tool in elucidating the pathways contributing to oncogenesis and evaluating the efficacy and specificity of cancer therapeutics. Researchers employ this compound to analyze cellular responses, genetic expressions, and the impact of pathway interference, thereby advancing our understanding of cancer biology and potential treatment avenues.

ML241 is a potent and selective inhibitors of p97 ATPase.